[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612844":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":43,"responsibleParty":76,"collaborators":78,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":84,"sex":89,"minAge":90,"maxAge":10,"enrollmentInfo":91,"targetDuration":10,"studyType":94,"phases":10,"briefSummary":95,"conditions":96,"keywords":98,"overallStatus":105,"whyStopped":10,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Hôpital NOVO","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Inflammatory catheters",null,"Catheter removed because of infection at insertion site",[13],"Diagnostic Test: Inflammatory catheters: catheter removed because of infection at insertion site",{"label":15,"type":10,"description":16,"interventionNames":17},"Non-inflammatory catheters","catheter removed because it is no longer relevant to keep it in place",[18],"Device: Non-inflammatory catheters: catheter removed because it is no longer relevant to keep it in place",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","Inflammatory catheters: catheter removed because of infection at insertion site","Verification of inclusion and non-inclusion criteria (at least 2 days and at most 7 days, with or without signs of inflammation).\n\nThe doctor or a qualified nurse orally informs the patient when catheter removal is planned.\n\nThe information and non-opposition note are given to the patient, and the information procedure is recorded in the medical record.\n\nThe catheter is removed and collected under aseptic conditions by the nurses in the various departments, in a dry sterile tube. The tube is then labelled and stored at a maximum of 4°C. The catheter is sent to the hospital's biology laboratory before being collected by the approved carrier for delivery to the ERRMECe laboratory from CYU. All tests are performed in the ERRMECe laboratory. Collected catheters are subsequently analysed to assess the bacterial diversity of biofilms using molecular biology techniques and Next-Generation Sequencing (NGS), in parallel with biofilm structural analysis microscopy using a Scanning Electron Microsc",[9],{"type":26,"name":27,"description":23,"armGroupLabels":28,"otherNames":10},"DEVICE","Non-inflammatory catheters: catheter removed because it is no longer relevant to keep it in place",[15],[30],{"name":31,"affiliation":5,"role":32},"LECURU Marion, Doctor","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},"Maryline DELATTRE","CONTACT","+33130755031","maryline.delattre@ght-novo.fr",{"name":40,"role":36,"phone":41,"phoneExt":10,"email":42},"Marylise ADECHIAN","+33130755069","marylise.adechian@ght-novo.fr",[44,63],{"facility":45,"status":10,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Hopital Novo","Cergy-Pontoise","Hopital NOVO","95303","France","FR",{"type":52,"coordinates":53},"Point",[54,55],2.07805,49.03894,{"lat":55,"lon":54},[58,61],{"name":35,"role":36,"phone":59,"phoneExt":10,"email":60},"+33130754131","promotion-usrc@ght-novo.fr",{"name":62,"role":36,"phone":10,"phoneExt":10,"email":10},"DELATTRE",{"facility":64,"status":10,"city":65,"state":10,"zip":10,"country":49,"countryCode":50,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"CY Cergy Paris Université","Neuville-sur-Oise",{"type":52,"coordinates":67},[68,69],2.06667,49.01667,{"lat":69,"lon":68},[72],{"name":73,"role":36,"phone":74,"phoneExt":10,"email":75},"SEYER Damien, Phd","+33 1 34 25 66 96","damien.seyer@cyu.fr",{"type":77,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[79],{"name":80,"class":81},"Université de Cergy Pontoise","UNKNOWN","100612844","analysis-of-microbial-biofilms-in-peripheral-venous-catheters-and-their-implication-in-infectious-risk-100612844",false,"NCT07258862","Analysis of Microbial Biofilms in Peripheral Venous Catheters and Their Implication in Infectious Risk","KTBIO","Inclusion Criteria:\n\n* Patient hospitalized in a care unit of the NOVO hospital (Pontoise site)\n* Major patient for whom a peripheral venous catheter has been in place for at least 2 days and at most 7 days, with or without signs of inflammation\n\nExclusion Criteria:\n\n* Antibiotic treatment by any route\n* Patient with viral hepatitis, or human immunodeficiency virus (HIV) or suspected epidemic and biological risk (EBR)\n* Patient unable to understand and give non-opposition to study participation\n* Patient under guardianship","ALL","18 Years",{"count":92,"type":93},250,"ESTIMATED","OBSERVATIONAL","Peripheral venous catheters (PVCs) are the most commonly used intravascular medical devices in healthcare establishments. Although essential in patient care, PVCs represent a significant risk factor for nosocomial infections, as shown by the results of the national prevalence survey. While the main pathophysiological mechanisms are known, the specific factors driving the transition from simple colonization to infection remain unclear. This project aims to identify the major factors involved in the occurrence of bacterial infections related to the colonization of peripheral venous catheters.",[97],"Catheter-Related Infections",[99,100,97,101,102,103,104],"Vascular Access Devices","Peripheral Venous Catheter","Biofilms","Molecular Biology","Next-Generation Sequencing","Scanning Electron Microscopy","NOT_YET_RECRUITING","2025-11-21",{"date":108,"type":109},"2025-12-02","ACTUAL",{"date":111,"type":93},"2026-01-01",{"date":113,"type":93},"2027-03-28",{"name":5,"class":6},2]